We are pleased to share that dapagliflozin and dapagliflozin-metformin, the generic equivalents of Farxiga and Xigduo, are now available as a Tier 1 medication and at no cost to Medicare Part D patients. Please share this update with your Medicare patients who are currently prescribed these or any SGLT2 medications (e.g. Brenzavvy, Invokana, Jardiance, Steglartro, Synjardy) as they may benefit from a generic, no-cost prescription. By prescribing the generic when needed, you can help improve access and encourage patients to take their medication as directed without financial obstacles.
As Tier 1 medications, these prescriptions are available at $0 and may be dispensed as an extended day supply of up to 180 days. This benefit allows eligible patients to receive a longer supply of their medication at no cost, helping to:
- Reduce out-of-pocket expenses
- Minimize pharmacy visits
- Support consistent medication adherence
When appropriate, we encourage providers to consider extended-day supplies to help support medication adherence and reduce pharmacy visits for patients managing chronic conditions.
Questions?
Thank you for your partnership in supporting your patients’ health. If you have any questions, please contact your provider representative.